Background The immune system interacts with cancer cells in various intricate ways that can
protect the individual from overproliferation of cancer cells; however, these interactions can …

The field of cancer immunotherapy has shown significant growth, and researchers are now
focusing on effective strategies to enhance and prolong local immunomodulation. Injectable …

Magnetic hyperthermia therapy (MHT) is a promising new modality to deal with solid tumors,
yet the low magnetic-heat conversion efficacy, magnetic resonance imaging (MRI) artifacts …

Certain chemotherapeutics and forms of ionizing radiation can induce immunogenic cell
death (ICD). If there simultaneously exist immune adjuvants within the tumor, such antitumor …

Metastasis is the leading cause of cancer‐associated death, with poor prognosis even after
extensive treatment. The dormancy of metastatic cancer cells during dissemination or after …

Despite the great promise achieved by immune checkpoint blockade (ICB) therapy in
harnessing the immune system to combat different tumors, limitations such as low objective …

Though increasing understanding and remarkable clinical successes have been made,
enormous challenges remain to be solved in the field of cancer immunotherapy. In this …

Cancer vaccines that elicit a robust and durable antitumor response show great promise in
cancer immunotherapy. Nevertheless, low immunogenicity and weak immune response limit …

Localized cancer therapy with combination of drugs is an effective treatment modality which
increase inhibition of tumor growth and reoccurrence. Recently, hydrogels that can …

Immunotherapy that boosts the body's immune system to treat local and distant metastatic
tumors has offered a new treatment option for cancer. However, cancer immunotherapy via …